Literature DB >> 26058345

Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project.

Santos Castañeda1, María A Martín-Martínez2, Carlos González-Juanatey3, Javier Llorca4, María J García-Yébenes2, Sabina Pérez-Vicente2, Jesús T Sánchez-Costa2, Federico Díaz-Gonzalez5, Miguel A González-Gay6.   

Abstract

OBJECTIVE: To establish the cardiovascular (CV) morbidity and associated risk factors for CV disease (CVD) in Spanish patients with chronic inflammatory rheumatic diseases (CIRD) and unexposed individuals attending rheumatology clinics.
METHODS: Analysis of data from the baseline visit of a 10-year prospective study [CARdiovascular in rheuMAtology (CARMA) project] that includes a cohort of patients with CIRD [rheumatoid arthritis (RA), ankylosing spondylitis (AS), and psoriatic arthritis (PsA)] and another cohort of matched individuals without CIRD attending outpatient rheumatology clinics from 67 hospitals in Spain. Prevalence of CV morbidity, CV risk factors, and systematic coronary risk evaluation (SCORE) assessment were analyzed.
RESULTS: A total of 2234 patients (775 RA, 738 AS, and 721 PsA) and 677 unexposed subjects were included. Patients had low disease activity at the time of recruitment. PsA patients had more commonly classic CV risk factors and metabolic syndrome features than did the remaining individuals. The prevalence of CVD was higher in RA (10.5%) than in AS (7.6%), PsA (7.2%), and unexposed individuals (6.4%). A multivariate analysis adjusted for the presence of classic CV risk factors and disease duration revealed a positive trend for CVD in RA (OR = 1.58; 95% CI: 0.90-2.76; p = 0.10) and AS (OR = 1.77; 95% CI: 0.96-3.27; p = 0.07). Disease duration in all CIRD groups and functional capacity (HAQ) in RA were associated with an increased risk of CVD (OR = 2.15; 95% CI: 1.29-3.56; p = 0.003). Most patients had a moderate CV risk according to the SCORE charts.
CONCLUSIONS: Despite recent advances in the management of CIRD, incidence of CVD remains increased in Spanish subjects with CIRD attending outpatient rheumatology clinics.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ankylosing spondylitis; Cardiovascular morbidity; Cardiovascular risk; Psoriatic arthritis; Rheumatoid arthritis

Mesh:

Year:  2014        PMID: 26058345     DOI: 10.1016/j.semarthrit.2014.12.002

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  38 in total

Review 1.  Atherosclerotic cardiovascular disease prevention in rheumatoid arthritis.

Authors:  Anne Grete Semb; Eirik Ikdahl; Grunde Wibetoe; Cynthia Crowson; Silvia Rollefstad
Journal:  Nat Rev Rheumatol       Date:  2020-06-03       Impact factor: 20.543

2.  High prevalence of subclinical atherosclerosis in psoriatic arthritis patients: a study based on carotid ultrasound.

Authors:  Rosario Ibáñez-Bosch; Juliana Restrepo-Velez; Miguel Medina-Malone; Laura Garrido-Courel; Inmaculada Paniagua-Zudaire; Eduardo Loza-Cortina
Journal:  Rheumatol Int       Date:  2016-11-24       Impact factor: 2.631

3.  Expert recommendations on the psychological needs of patients with rheumatoid arthritis.

Authors:  Leticia Leon; Marta Redondo; Antonio Fernández-Nebro; Susana Gómez; Estíbaliz Loza; María Montoro; Rosario Garcia-Vicuña; María Galindo
Journal:  Rheumatol Int       Date:  2018-05-28       Impact factor: 2.631

4.  Cardiovascular risk estimation in young patients with ankylosing spondylitis: A new model based on a prospective study in Constanta County, Romania.

Authors:  Mihaela Ionescu; Paris Ionescu; Adrian Paul Suceveanu; Anca Pantea Stoian; Ion Motofei; Valeriu Ardeleanu; Irinel-Raluca Parepa
Journal:  Exp Ther Med       Date:  2021-03-22       Impact factor: 2.447

Review 5.  Sex and Cardiovascular Involvement in Inflammatory Joint Diseases.

Authors:  Santos Castañeda; Carlos González-Juanatey; Miguel A González-Gay
Journal:  Clin Rev Allergy Immunol       Date:  2019-06       Impact factor: 8.667

6.  Gaps in Diagnosis and Treatment of Cardiovascular Risk Factors in Patients with Psoriatic Disease: An International Multicenter Study.

Authors:  Lihi Eder; Paula Harvey; Vinod Chandran; Cheryl F Rosen; Jan Dutz; James T Elder; Proton Rahman; Christopher T Ritchlin; Sherry Rohekar; Richard Hayday; Snezana Barac; Joy Feld; Devy Zisman; Dafna D Gladman
Journal:  J Rheumatol       Date:  2018-02-01       Impact factor: 4.666

7.  Prevalence and type II diabetes-associated factors in psoriatic arthritis.

Authors:  Rubén Queiro; Andrés Lorenzo; Estefanía Pardo; Anahy Brandy; Pablo Coto; Javier Ballina
Journal:  Clin Rheumatol       Date:  2018-02-22       Impact factor: 2.980

8.  Prevalence of cardiovascular-related comorbidity in ankylosing spondylitis, psoriatic arthritis and psoriasis in primary care: a matched retrospective cohort study.

Authors:  Nadeem Ahmed; James A Prior; Ying Chen; Richard Hayward; Christian D Mallen; Samantha L Hider
Journal:  Clin Rheumatol       Date:  2016-08-02       Impact factor: 2.980

9.  Adipokine role in physiopathology of inflammatory and degenerative musculoskeletal diseases.

Authors:  Liberato Giardullo; Addolorata Corrado; Nicola Maruotti; Daniela Cici; Natalia Mansueto; Francesco Paolo Cantatore
Journal:  Int J Immunopathol Pharmacol       Date:  2021 Jan-Dec       Impact factor: 3.219

10.  Diabetes mellitus and cardiovascular risk management in patients with rheumatoid arthritis: an international audit.

Authors:  Anne Grete Semb; Silvia Rollefstad; Eirik Ikdahl; Grunde Wibetoe; Joseph Sexton; Cindy Crowson; Piet van Riel; George Kitas; Ian Graham; Solbritt Rantapää-Dahlqvist; George Athanasios Karpouzas; Elena Myasoedova; Miguel A Gonzalez-Gay; Petros P Sfikakis; Maria G Tektonidou; Argyro Lazarini; Dimitrios Vassilopoulos; Bindee Kuriya; Carol Hitchon; Maria Simona Stoenoiu; Patrick Durez; Virginia Pascual-Ramos; Dionicio Angel Galarza-Delgado; Pompilio Faggiano; Durga Prasanna Misra; Andrew A Borg; Rong Mu; Erkin M Mirrakhimov; Diane Gheta; Karen Douglas; Vikas Agarwal; Svetlana Myasoedova; Lev Krougly; Tatiana Valentinovna Popkova; Alena Tuchyňová; Michal Tomcik; Michal Vrablik; Jiri Lastuvka; Pavel Horak; Helena Kaspar Medkova; Anne M Kerola
Journal:  RMD Open       Date:  2021-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.